IL214913A - Reversed stabilized transcriptase fusion proteins - Google Patents

Reversed stabilized transcriptase fusion proteins

Info

Publication number
IL214913A
IL214913A IL214913A IL21491311A IL214913A IL 214913 A IL214913 A IL 214913A IL 214913 A IL214913 A IL 214913A IL 21491311 A IL21491311 A IL 21491311A IL 214913 A IL214913 A IL 214913A
Authority
IL
Israel
Prior art keywords
fusion proteins
reverse transcriptase
transcriptase fusion
stabilized reverse
stabilized
Prior art date
Application number
IL214913A
Other languages
English (en)
Hebrew (he)
Other versions
IL214913A0 (en
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of IL214913A0 publication Critical patent/IL214913A0/en
Publication of IL214913A publication Critical patent/IL214913A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07049RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/24Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL214913A 2009-03-04 2011-09-01 Reversed stabilized transcriptase fusion proteins IL214913A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15733209P 2009-03-04 2009-03-04
PCT/US2010/026165 WO2010102085A2 (en) 2009-03-04 2010-03-04 Stabilized reverse transcriptase fusion proteins

Publications (2)

Publication Number Publication Date
IL214913A0 IL214913A0 (en) 2011-11-30
IL214913A true IL214913A (en) 2017-06-29

Family

ID=42710216

Family Applications (1)

Application Number Title Priority Date Filing Date
IL214913A IL214913A (en) 2009-03-04 2011-09-01 Reversed stabilized transcriptase fusion proteins

Country Status (11)

Country Link
US (4) US10113156B2 (https=)
EP (2) EP2403941B1 (https=)
JP (2) JP5882064B2 (https=)
CN (1) CN102421791A (https=)
AU (1) AU2010221284B2 (https=)
BR (1) BRPI1009221A2 (https=)
CA (1) CA2754476A1 (https=)
IL (1) IL214913A (https=)
MX (1) MX2011009205A (https=)
WO (1) WO2010102085A2 (https=)
ZA (1) ZA201107207B (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101818126B1 (ko) * 2011-02-09 2018-01-15 (주)바이오니아 열안정성이 증가된 역전사효소
AU2012220596B2 (en) * 2011-02-23 2016-05-12 Board Of Regents Use of template switching for DNA synthesis
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
IL310721B2 (en) 2015-10-23 2025-11-01 Harvard College Nucleobase editors and uses thereof
CN108368151B (zh) 2015-12-07 2022-11-15 生物辐射实验室股份有限公司 二聚逆转录酶
CN110214183A (zh) 2016-08-03 2019-09-06 哈佛大学的校长及成员们 腺苷核碱基编辑器及其用途
WO2018031683A1 (en) 2016-08-09 2018-02-15 President And Fellows Of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
KR102622411B1 (ko) 2016-10-14 2024-01-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
US12390514B2 (en) 2017-03-09 2025-08-19 President And Fellows Of Harvard College Cancer vaccine
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
US11542496B2 (en) 2017-03-10 2023-01-03 President And Fellows Of Harvard College Cytosine to guanine base editor
KR20240116572A (ko) 2017-03-23 2024-07-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
WO2019070843A1 (en) * 2017-10-03 2019-04-11 Board Of Regents, The University Of Texas System INVERSE TRANSCRIPTASE WITH LTR-FREE BACKLIGHTS AND USES THEREOF
KR20250107288A (ko) 2017-10-16 2025-07-11 더 브로드 인스티튜트, 인코퍼레이티드 아데노신 염기 편집제의 용도
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
US12522807B2 (en) 2018-07-09 2026-01-13 The Broad Institute, Inc. RNA programmable epigenetic RNA modifiers and uses thereof
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
WO2020191233A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
WO2020252455A1 (en) 2019-06-13 2020-12-17 The General Hospital Corporation Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
WO2021165273A1 (en) * 2020-02-17 2021-08-26 Leadxpro Ag Pro-macrobodies for the enhancement of structure research
CN116209756A (zh) 2020-03-04 2023-06-02 旗舰先锋创新Vi有限责任公司 调控基因组的方法和组合物
IL297761A (en) 2020-05-08 2022-12-01 Broad Inst Inc Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
CA3189601A1 (en) 2020-07-24 2022-01-27 The General Hospital Corporation Enhanced virus-like particles and methods of use thereof for delivery to cells
CA3193099A1 (en) 2020-09-24 2022-03-31 David R. Liu Prime editing guide rnas, compositions thereof, and methods of using the same
EP4274894A2 (en) 2021-01-11 2023-11-15 The Broad Institute, Inc. Prime editor variants, constructs, and methods for enhancing prime editing efficiency and precision
JP2024530487A (ja) 2021-08-06 2024-08-21 ザ ブロード インスティテュート,インコーポレーテッド 改善されたプライムエディターおよび使用方法
EP4137582B1 (en) * 2021-08-17 2026-01-28 New England Biolabs, Inc. Rolling circle reverse transcription of circular rna
AU2022343268A1 (en) 2021-09-08 2024-03-28 Flagship Pioneering Innovations Vi, Llc Methods and compositions for modulating a genome
WO2023076898A1 (en) 2021-10-25 2023-05-04 The Broad Institute, Inc. Methods and compositions for editing a genome with prime editing and a recombinase
WO2023102538A1 (en) 2021-12-03 2023-06-08 The Broad Institute, Inc. Self-assembling virus-like particles for delivery of prime editors and methods of making and using same
WO2023205687A1 (en) 2022-04-20 2023-10-26 The Broad Institute, Inc. Improved prime editing methods and compositions
WO2023240137A1 (en) 2022-06-08 2023-12-14 The Board Institute, Inc. Evolved cas14a1 variants, compositions, and methods of making and using same in genome editing
WO2024077267A1 (en) 2022-10-07 2024-04-11 The Broad Institute, Inc. Prime editing methods and compositions for treating triplet repeat disorders
EP4619515A1 (en) 2022-11-17 2025-09-24 The Broad Institute, Inc. Prime editor delivery by aav
WO2024168147A2 (en) 2023-02-09 2024-08-15 The Broad Institute, Inc. Evolved recombinases for editing a genome in combination with prime editing
WO2024206125A1 (en) 2023-03-24 2024-10-03 The Broad Institute, Inc. Use of prime editing for treating sickle cell disease
AU2024357861A1 (en) 2023-10-12 2026-04-23 Renagade Therapeutics Management Inc. Nickase-retron template-based precision editing system and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5643758A (en) 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
US5654176A (en) 1987-05-28 1997-08-05 Amrad Corporation Limited Fusion proteins containing glutathione-s-transferase
US5736373A (en) * 1996-09-23 1998-04-07 Becton, Dickinson And Company Thermostable DNA polymerase from Bacillus pallidus
US7001745B1 (en) 1998-09-30 2006-02-21 New England Biolabs, Inc. Intein mediated peptide ligation
US6436677B1 (en) 2000-03-02 2002-08-20 Promega Corporation Method of reverse transcription
US6627424B1 (en) * 2000-05-26 2003-09-30 Mj Bioworks, Inc. Nucleic acid modifying enzymes
US7507412B2 (en) 2001-07-18 2009-03-24 Merck Patent Gmbh Glycoprotein VI fusion proteins
US7670807B2 (en) * 2004-03-10 2010-03-02 East Tennessee State Univ. Research Foundation RNA-dependent DNA polymerase from Geobacillus stearothermophilus
US7935509B2 (en) 2004-08-13 2011-05-03 New England Biolabs, Inc. Intracellular production of a nuclease

Also Published As

Publication number Publication date
AU2010221284A1 (en) 2011-10-27
WO2010102085A4 (en) 2011-01-06
AU2010221284B2 (en) 2015-10-01
US20180340158A1 (en) 2018-11-29
WO2010102085A2 (en) 2010-09-10
BRPI1009221A2 (pt) 2016-03-15
EP2403941A2 (en) 2012-01-11
EP2403941B1 (en) 2018-10-03
JP2015193666A (ja) 2015-11-05
US20180346890A1 (en) 2018-12-06
IL214913A0 (en) 2011-11-30
US10858636B2 (en) 2020-12-08
JP2012519489A (ja) 2012-08-30
US20120009630A1 (en) 2012-01-12
ZA201107207B (en) 2012-12-27
JP5882064B2 (ja) 2016-03-09
US10113156B2 (en) 2018-10-30
CN102421791A (zh) 2012-04-18
US10150955B2 (en) 2018-12-11
WO2010102085A3 (en) 2010-11-18
EP2403941A4 (en) 2012-09-05
MX2011009205A (es) 2011-09-30
CA2754476A1 (en) 2010-09-10
EP3415621A1 (en) 2018-12-19
US20160289652A1 (en) 2016-10-06

Similar Documents

Publication Publication Date Title
IL214913A0 (en) Stabilized reverse transcriptase fusion proteins
IL275846A (en) ACTRIIB–FC truncated fusion proteins
PL2406399T3 (pl) Białka mirac
PL2410869T3 (pl) Odzyskiwanie białka
ZA201106638B (en) Anti-angiogenic fusion proteins
IL215005A0 (en) Ox40/trail fusion proteins
IL216097A0 (en) Anti-axl antibody
DK2319462T3 (da) Protese med komposit komponent
GB0901228D0 (en) Aircraft joint
ZA201106663B (en) Fused pyrimidines
SG10201500208SA (en) Npp1 fusion proteins
GB0901640D0 (en) Joint
EP2480578A4 (en) MODIFICATION OF POLYPEPTIDE
IL240134A0 (en) new proteins
ZA201109283B (en) Protein
GB0921691D0 (en) Sophorolpid transporter protien
GB2477186B (en) Fusion protein having luminescence activity
GB0904177D0 (en) Fusion polypeptide
GB0914019D0 (en) Fusion polypeptide
GB0910319D0 (en) Fusion polypeptides
GB0910466D0 (en) Fusion polypeptides
GB0904647D0 (en) Modified receptor fusion proteins
GB0913905D0 (en) Somatostatin fusion polypeptides
GB0908056D0 (en) Somatostatin fusion polypeptides
GB0713169D0 (en) Fusion proteins

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed